secwatch.observer — SEC 8-K summary
======================================

Issuer:     Stereotaxis, Inc. (STXS)
CIK:        0001289340
Form:       8-K
Filed at:   2026-03-09T23:59:59+00:00
Accession:  0001493152-26-009366
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stereotaxis reports Q4 2025 revenue $8.6M (+36% YoY); guides FY2026 revenue >$40M
--------------------------------------------------------------------------------

- Q4 2025 revenue $8.6M (+36% YoY); system rev $3.3M, recurring $5.3M.
- Full year 2025 revenue $32.4M (+20% YoY); guidance for 2026 to surpass $40M.
- Q4 net loss $5.5M vs $7.5M prior year; adjusted net loss $2.5M vs $3.6M.
- Cash $13.4M, no debt; raised $3.1M in ATM offering at avg $3.17/share.
- Key 2026 milestones: 5 GenesisX programs, ramp MAGiC to 500/month, FDA approval for Synchrony.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1289340/000149315226009366/0001493152-26-009366-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1289340/000149315226009366/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-009366

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer